Abstract
The present work addresses one of the currently most controversial aspects of early detection of Alzheimers disease (AD) and other dementias; that is, the identification of the Mild Cognitive Impairment (MCI) syndrome — in some cases, prior to AD — in a sample of older subjects who are healthy from the cognitive viewpoint. In a three-year longitudinal study, we classified the participants between 58 and 90 years of age in different cognitive profiles: healthy and MCI (amnestic MCI, non-amnestic MCI, and multi-domain MCI). We followed the evolution of each one by means of the administration on three occasions of an extensive battery of neuropsychological tests. We have found a high percentage of MCI in our sample. Although some of them were amnestic MCIs, this group was not the most frequent. The multi-domain MCI is the one that evolves directly into AD, not the amnestic MCIs. We have found diverse evolutional trajectories over the past three years, some expected, others somewhat unexpected. We also point out the methodological difficulties posed by the administration of certain episodic memory tests, which is not the most appropriate to detect subclinical MCI, due to the effect of practice.
Keywords: Mild cognitive impairment, conversion to Alzheimer disease, cognitive subprofiles, cognitive markers, Aging, Syndrome, Episodic memory, Dementia, Depression, Neuropsychological assessments
Current Aging Science
Title: Evolution of Specific Cognitive Subprofiles of Mild Cognitive Impairment in a Three-Year Longitudinal Study
Volume: 4 Issue: 2
Author(s): H. Peraita, S. Garcia-Herranz and C. Diaz-Mardomingo
Affiliation:
Keywords: Mild cognitive impairment, conversion to Alzheimer disease, cognitive subprofiles, cognitive markers, Aging, Syndrome, Episodic memory, Dementia, Depression, Neuropsychological assessments
Abstract: The present work addresses one of the currently most controversial aspects of early detection of Alzheimers disease (AD) and other dementias; that is, the identification of the Mild Cognitive Impairment (MCI) syndrome — in some cases, prior to AD — in a sample of older subjects who are healthy from the cognitive viewpoint. In a three-year longitudinal study, we classified the participants between 58 and 90 years of age in different cognitive profiles: healthy and MCI (amnestic MCI, non-amnestic MCI, and multi-domain MCI). We followed the evolution of each one by means of the administration on three occasions of an extensive battery of neuropsychological tests. We have found a high percentage of MCI in our sample. Although some of them were amnestic MCIs, this group was not the most frequent. The multi-domain MCI is the one that evolves directly into AD, not the amnestic MCIs. We have found diverse evolutional trajectories over the past three years, some expected, others somewhat unexpected. We also point out the methodological difficulties posed by the administration of certain episodic memory tests, which is not the most appropriate to detect subclinical MCI, due to the effect of practice.
Export Options
About this article
Cite this article as:
Peraita H., Garcia-Herranz S. and Diaz-Mardomingo C., Evolution of Specific Cognitive Subprofiles of Mild Cognitive Impairment in a Three-Year Longitudinal Study, Current Aging Science 2011; 4 (2) . https://dx.doi.org/10.2174/1874609811104020171
DOI https://dx.doi.org/10.2174/1874609811104020171 |
Print ISSN 1874-6098 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-6128 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Analytical Procedure for Determination of Cyclooxygenase-2 Inhibitors in Biological Fluids by High Performance Liquid Chromatography: A Review
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Native Proteins in Organic Chemistry. Recent Achievements in the use of non Hydrolytic Enzymes for the Synthesis of Pharmaceuticals
Current Organic Chemistry Melatonin Role in Experimental Arthritis
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Fabry Disease Cardiomyopathy: from Genes to Clinical Manifestations
Current Pharmaceutical Biotechnology RNA Splicing Manipulation: Strategies to Modify Gene Expression for a Variety of Therapeutic Outcomes
Current Gene Therapy Animal Models in Neurology: Drawbacks and Opportunities
Current Pharmaceutical Design Prediction of Comparative Inhibition Efficiency for a Novel Natural Ligand, Galangin Against Human Brain Acetylcholinesterase, Butyrylcholinesterase and 5-Lipoxygenase: A Neuroinformatics Study
CNS & Neurological Disorders - Drug Targets Micro-RNA in Disease and Gene Therapy
Current Drug Discovery Technologies Molecular Hydrogen as a Neuroprotective Agent
Current Neuropharmacology Aminotransferase Serum Levels Decrease after Initiating Antiretroviral Treatment in HIV Infected Patients
Current HIV Research Hyperglycemia-induced Oxidative Stress and its Role in Diabetes Mellitus Related Cardiovascular Diseases
Current Pharmaceutical Design The Relationship between Inflammatory and Oxidative Stress Biomarkers, Atherosclerosis and Rheumatic Diseases
Current Pharmaceutical Design Editorial: In Silico Studies in Drug Research Against Neurodegenerative Diseases
Current Neuropharmacology Severe Acute Respiratory Syndrome Coronavirus 2 is Penetrating to Dementia Research
Current Neurovascular Research Statin Treatment and the Natural History of Atherosclerotic-Related Diseases: Pathogenic Mechanisms and the Risk-Benefit Profile
Current Pharmaceutical Design Trigonelline: A Plant Alkaloid with Therapeutic Potential for Diabetes and Central Nervous System Disease
Current Medicinal Chemistry Preface [ Focus on NeuroAIDS ]
Current HIV Research Cardiovascular Risk Factors in Chronic Inflammatory Rheumatic Diseases: Modern Assessment and Diagnosis
Current Vascular Pharmacology A Computational Approach to Finding RNA Tertiary Motifs in Genomic Sequences: A Case Study
Recent Patents on DNA & Gene Sequences Detour Cum Distance Matrix Based Topological Descriptors for QSAR/QSPR Part-II: Application in Drug Discovery Process
Letters in Drug Design & Discovery